Author

Murat Toruner 1

1 Ankara University Medical School,Ankara,Turkey

Burden of Gastrointestinal Symptoms and Disease in Turkey: Cappadocia Cohort Study

Orhan Sezgin, Hale Akpınar, Birol Özer, Murat Toruner, Kadir Bal, Serhat Bor

Incidence and indicators of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialized countries: Results from the EXPLORE study

Jesus Kazuo Yamamoto-Furusho, Othman Al Harbi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina V. Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M Rana-Khan, Alessandro Armuzzi

NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

Aykut Ferhat Çelik, Sinem Nihal Esatoglu, Murat Toruner, Gulen Hatemi, Ahmet Tezel, Ismail Hakkı Kalkan, Hulya Hamzaoglu, Hale Akpınar

The Efficacy and The Safety of Vedolizumab in a Group of anti-TNF experienced patients with IBD ; A Real-Life Data from Turkey

Murat Toruner, suleyman YILDIRIM, Hülya Över Hamzaoğlu, Yusuf Ziya Erzin, Hülya Çetinkaya, Ali Ibrahim Hatemi, Aykut Ferhat Çelik

THE LONG-TERM EFFECT OF ANTI-TNF ΑLPHA THERAPY ON SERUM LIPID PROFILE AND ATHEROGENIC INDEX IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Çağdaş Kalkan, Fatih Karakaya, Emra Asfuroğlu Kalkan, Ali Emrehan Tüzün, Zeynep Gençtürk, Murat Toruner, Hülya Çetinkaya, Irfan Soykan

Item 1 - 5 / 7
1